Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 8,486 | 12,344 | 7,804 | 4,234 | 3,956 |
| Cost of Goods | 9,287 | 6,685 | 6,495 | 6,600 | 3,357 |
| Gross Profit | -801 | 5,659 | 1,309 | -2,366 | 599 |
| Operating Expenses | 15,192 | 12,970 | 12,941 | 12,949 | 9,689 |
| Operating Income | -15,706 | -6,626 | -11,137 | -14,715 | -8,733 |
| Interest Expense | 456 | 494 | 514 | 713 | 910 |
| Other Income | 417 | -1,176 | -243 | 146 | 135 |
| Pre-tax Income | -15,745 | -8,296 | -11,894 | -15,282 | -9,508 |
| Net Income Continuous | -15,745 | -8,296 | -11,894 | -15,282 | -9,508 |
| Net Income | $-15,745 | $-8,296 | $-11,894 | $-15,282 | $-9,508 |
| EPS Basic Total Ops | -0.49 | -0.27 | -0.47 | -0.60 | -0.55 |
| EPS Basic Continuous Ops | -0.49 | -0.27 | -0.47 | -0.60 | -0.55 |
| EPS Diluted Total Ops | -0.49 | -0.27 | -0.47 | -0.60 | -0.55 |
| EPS Diluted Continuous Ops | -0.49 | -0.27 | -0.47 | -0.60 | -0.55 |
| EBITDA(a) | $-14,090 | $-5,074 | $-9,710 | $-13,383 | $-7,505 |